Abiopharma

NeuroSense Issues CEO Letter to Shareholders

Director Hutson Richard M II 🟢 acquired 212 shares of INVESTORS TITLE CO (ITIC) at $122.80 Transaction Date: Aug 12, 2026 | Filing ID: 000006

ComEd Restores Power to More Than 80 Percent of Customers Impacted by August 11 and 12 Storms

Clinical trial NCT06849869 updates: 1. completion date: 2028-06-30 → 2029-03-30 2. primary completion date: 2028-06-30 → 2029-01-30

Clinical trial NCT06873945 updates: 1. status: ACTIVE_NOT_RECRUITING → RECRUITING 2. completion date: 2026-12-21 → 2028-03-19 3. primary completion date: 2026-12-21 → 2028-03-19 4. enrollment: 550 → 1330 participants 5. enrollment type: ACTUAL → ESTIMATED

Clinical trial NCT06992544 updates: 1. completion date: 2026-07-01 → 2026-11-01 2. primary completion date: 2026-07-01 → 2026-11-01

Clinical trial NCT06252753 updates: 1. start date: 2023-12-20 → 2023-12-19 2. enrollment: 4490 → 4000 participants

Clinical trial NCT06269120 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-03-31 → 2026-05-05 3. primary completion date: 2026-03-31 → 2026-05-05 4. enrollment: 470 → 243 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07166393 updates: 1. start date: 2026-05-01 → 2027-05-01 2. completion date: 2030-12-01 → 2031-12-01 3. primary completion date: 2030-02-01 → 2031-05-01

Clinical trial NCT06975787 updates: 1. completion date: 2029-09-09 → 2029-09-10 2. primary completion date: 2029-09-09 → 2029-09-10

Clinical trial NCT05572684 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2025-11-01 → 2025-04-30 3. primary completion date: 2025-07-01 → 2025-04-30

Clinical trial NCT04628871 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2030-01-01 → 2026-06-17 3. primary completion date: 2030-01-01 → 2026-06-17 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04924101: enrollment: 126 → 122 participants.

Clinical trial NCT07641881 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-07-01 → 2026-08-07 3. primary completion date: 2026-07-01 → 2026-07-03 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06955169 updates: 1. status: SUSPENDED → ACTIVE_NOT_RECRUITING 2. enrollment: 153 → 4 participants 3. enrollment type: ESTIMATED → ACTUAL